PTPRZ1 and neoplasm: Glioblastoma tumor stem cells (CSCs) have large amounts of its receptor, PTPRZ1, which activate a series of signaling pathways that produce CSCs and maintain their malignant behavior, promoting tumor growth and progression and leading to increased mortality in patients (Shi et al., 2017).